Advanced search
News (96)
Companies (1)
Camil Alimentos SA is a Brazil-based company primarily engaged in the food processing sector. The Company focuses on the manufacture and commercialization of rice, rice crackers, beans, peas, chickpeas and lentil seeds, soybean-based meals, popcorn, sugar ...
Insiders
Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Ernest Bedrosian was the President and Chief Executive Officer of Sunshine Raisin Corp.
John C.
Bedrosian is currently a Director at The International Dairy Foods Association, All Star Dairy Foods, Inc., and Dairy Institute of California.
He was formerly a Director at The American Institute of Baking and Vice President-Manufacturing at UNFI Grocers Distribution, Inc. Bedrosian obtained an undergraduate degree from The California State University.
Kimberly Bedrosian currently works at Sunshine Raisin Corp., as Director.
Mr. Bedrosian serves as the Chief Financial Office of Marcus & Millichap Company and is responsible for overseeing the entire finance function, including, capital markets, taxation, and treasury.
He also serves as a member of the Company's Investment Committee.
Mr. Bedrosian has significant experience within the real estate investment banking community and has acted as a strategic advisor to many private and public companies within the sector.
Prior to joining Marcus & Millichap Company, he was the Chief Financial Officer at Ramco-Gershenson Properties Trust, a publically-traded REIT, and served as the Managing Director in the Global Real Estate Investment Banking Group at Deutsche Bank Securities, Inc. Mr. Bedrosian earned a B.S.
in Finance and Administration from Mercy College and an M.S.
in Real Estate and Finance from New York University.
No results for this search
- Stock Market
- Advanced search
- Camille Bedrosian